Teladoc Health (TDOC) is a Healthcare company in the Health Information Services industry. It has a market capitalization of $1.60B and a free-cash-flow yield of 8.9%. Over the most recent reported fiscal year, revenue declined 1.5% and free cash flow per share fell 21.6%. Nama's AI scorecard rates it Hold, 5.0 out of 10. On 12-month momentum it ranks in the lagging band of its market.
AI scorecard
Hold · 5.0/10
The sections balance. As of Nov 7, 2026.
Momentum
Lagging · -27.0% over 12 months ex. last
Second-worst fifth of its market on the past year's move.
Shariah screen
Not Shariah Compliant
At least one of the three ratios or the industry test failed.
Off its high
-94.1%
How far the last close sits under the highest price of the past five years.
Market cap
$1.60B
Trailing P/E
—
Price / book
1.2
Price / sales
0.7
FCF yield
8.9%
Dividend yield
—
Gross margin
68.6%
Operating margin
-5.4%
Net margin
-6.3%
Revenue growth (YoY)
-1.5%
Revenue growth (3-yr annual)
+1.7%
EPS growth (YoY)
—
FCF/share growth (YoY)
-21.6%
Beta
2.1
Exchange
NYSE
Sector
Healthcare
Industry
Health Information Services
TDOC earnings
Next report: Feb 24, 2027 (Q4 2026, EPS estimate -$0.13).
Beat the EPS estimate in 4 of 4 recent quarters.
Quarter
Reported
EPS
Estimate
Surprise
Revenue
Q3 2026
Oct 28, 2026
-$0.12
-$0.19
+36.8%
$605.10M
Q2 2026
Jul 29, 2026
-$0.20
-$0.22
+9.1%
$606.93M
Q1 2026
Apr 29, 2026
-$0.28
-$0.39
+28.2%
$613.85M
Q4 2025
Feb 25, 2026
-$0.10
-$0.22
+54.5%
$642.27M
TDOC analyst price target
Median target $8.75 from 18 analysts, ranging $6.00 – $11.50.
Nama's AI scorecard currently rates Teladoc Health Hold (5.0 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
When does TDOC report earnings?
Teladoc Health's next scheduled report is on Feb 24, 2027. Analysts expect EPS of -$0.13.
What is the TDOC price target?
The median analyst price target from 18 analysts is $8.75, with a range of $6.00 – $11.50.
Is TDOC Shariah compliant?
Nama's AAOIFI-style screen reads Teladoc Health as Not Shariah Compliant. At least one of the three ratios or the industry test failed.